Spotlight Pathology Raises £1.4M To Accelerate AI Detection Of Blood Cancer

Blood cancers are often difficult to diagnose and typically require multiple reviews by specialist pathologists. At the same time, pathology departments across the UK face rising demand and shortages of trained staff, which can delay diagnoses and treatment.

Spotlight’s technology integrates into existing clinical workflows, helping pathologists prioritise cases and reach decisions sooner so patients can begin treatment earlier.

The company was founded by Dr Richard Byers, a consultant haematopathologist and Dr Martin Fergie, an AI specialist with over 15 years of experience developing healthcare algorithms. The new funding will support regulatory approvals and early clinical trials as the platform moves toward wider clinical use.

Read Also - Another Earth Raises €3.5M To Expand AI-Powered Earth Observation Platform

“Our mission is to support pathologists with tools that fit seamlessly into existing workflows helping them reach accurate diagnoses faster and with greater confidence.

This investment gives us the momentum to move from development into real-world clinical settings. We’re excited to be scaling the business from Daresbury, working alongside partners across the North West and beyond, and to be strengthening our board with experienced leadership as we enter this next phase.”

Sakura Holloway, Investment Director at the UK Innovation and Science Seed Fund, managed by Future Planet Capital, added: “Spotlight Pathology is a strong example of how UK university research can be translated into technologies that will transform patient outcomes. The team are addressing a critical challenge in blood cancer diagnosis and with the right leadership and support in place, the company is well positioned to bring this technology into clinical settings.

This investment reflects our conviction in both the team and the technology, and our commitment to backing spin-outs that apply advanced science to pressing healthcare challenges, improving productivity in the health system and delivering meaningful global patient impact."

About Spotlight Pathology

Spotlight Pathology develops AI powered decision support tools that help pathologists diagnose blood cancers more quickly and accurately. Its software analyses digital pathology images to assist clinicians in identifying complex cases streamlining diagnostic workflows and enabling earlier treatment decisions for patients facing life threatening blood cancer conditions.